BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 23755281)

  • 1. Association between cannabinoid CB₁ receptor expression and Akt signalling in prostate cancer.
    Cipriano M; Häggström J; Hammarsten P; Fowler CJ
    PLoS One; 2013; 8(6):e65798. PubMed ID: 23755281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid amide hydrolase in prostate cancer: association with disease severity and outcome, CB1 receptor expression and regulation by IL-4.
    Thors L; Bergh A; Persson E; Hammarsten P; Stattin P; Egevad L; Granfors T; Fowler CJ
    PLoS One; 2010 Aug; 5(8):e12275. PubMed ID: 20808855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour Cannabinoid CB(1) receptor and phosphorylated epidermal growth factor receptor expression are additive prognostic markers for prostate cancer.
    Fowler CJ; Hammarsten P; Bergh A
    PLoS One; 2010 Dec; 5(12):e15205. PubMed ID: 21203460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phospho-Akt immunoreactivity in prostate cancer: relationship to disease severity and outcome, Ki67 and phosphorylated EGFR expression.
    Hammarsten P; Cipriano M; Josefsson A; Stattin P; Egevad L; Granfors T; Fowler CJ
    PLoS One; 2012; 7(10):e47994. PubMed ID: 23133535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ErbB2 receptor immunoreactivity in prostate cancer: relationship to the androgen receptor, disease severity at diagnosis and disease outcome.
    Hammarsten P; Winther J; Rudolfsson SH; Häggström J; Karalija A; Egevad L; Granfors T; Fowler CJ
    PLoS One; 2014; 9(9):e105063. PubMed ID: 25215939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of phosphoinositide 3-kinase/PKB pathway by CB(1) and CB(2) cannabinoid receptors expressed in prostate PC-3 cells. Involvement in Raf-1 stimulation and NGF induction.
    Sánchez MG; Ruiz-Llorente L; Sánchez AM; Díaz-Laviada I
    Cell Signal; 2003 Sep; 15(9):851-9. PubMed ID: 12834810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A high cannabinoid CB(1) receptor immunoreactivity is associated with disease severity and outcome in prostate cancer.
    Chung SC; Hammarsten P; Josefsson A; Stattin P; Granfors T; Egevad L; Mancini G; Lutz B; Bergh A; Fowler CJ
    Eur J Cancer; 2009 Jan; 45(1):174-82. PubMed ID: 19056257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells.
    Morell C; Bort A; Vara D; Ramos-Torres A; Rodríguez-Henche N; Díaz-Laviada I
    Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):248-57. PubMed ID: 27324222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray.
    Häggström J; Cipriano M; Forshell LP; Persson E; Hammarsten P; Stella N; Fowler CJ
    Prostate; 2014 Aug; 74(11):1107-17. PubMed ID: 24913716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High tumour cannabinoid CB1 receptor immunoreactivity negatively impacts disease-specific survival in stage II microsatellite stable colorectal cancer.
    Gustafsson SB; Palmqvist R; Henriksson ML; Dahlin AM; Edin S; Jacobsson SO; Öberg Å; Fowler CJ
    PLoS One; 2011; 6(8):e23003. PubMed ID: 21901119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hierarchical clustering of immunohistochemical analysis of the activated ErbB/PI3K/Akt/NF-kappaB signalling pathway and prognostic significance in prostate cancer.
    Koumakpayi IH; Le Page C; Mes-Masson AM; Saad F
    Br J Cancer; 2010 Mar; 102(7):1163-73. PubMed ID: 20216540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
    Park SS; Kim SW
    Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cannabinoid receptors CB1 and CB2 form functional heteromers in brain.
    Callén L; Moreno E; Barroso-Chinea P; Moreno-Delgado D; Cortés A; Mallol J; Casadó V; Lanciego JL; Franco R; Lluis C; Canela EI; McCormick PJ
    J Biol Chem; 2012 Jun; 287(25):20851-65. PubMed ID: 22532560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour epithelial expression levels of endocannabinoid markers modulate the value of endoglin-positive vascular density as a prognostic marker in prostate cancer.
    Fowler CJ; Josefsson A; Thors L; Chung SC; Hammarsten P; Wikström P; Bergh A
    Biochim Biophys Acta; 2013 Oct; 1831(10):1579-87. PubMed ID: 23262399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Forkhead protein FKHR and its phosphorylated form p-FKHR in human prostate cancer.
    Li R; Erdamar S; Dai H; Wheeler TM; Frolov A; Scardino PT; Thompson TC; Ayala GE
    Hum Pathol; 2007 Oct; 38(10):1501-7. PubMed ID: 17597184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression patterns and predictive value of phosphorylated AKT in early-stage breast cancer.
    Andre F; Nahta R; Conforti R; Boulet T; Aziz M; Yuan LX; Meslin F; Spielmann M; Tomasic G; Pusztai L; Hortobagyi GN; Michiels S; Delaloge S; Esteva FJ
    Ann Oncol; 2008 Feb; 19(2):315-20. PubMed ID: 17804473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of phosphoprotein phosphatase 2A predicts worse prognosis in patients with breast cancer: a 15-year follow-up.
    Chen PM; Chu PY; Tung SL; Liu CY; Tsai YF; Lin YS; Wang WL; Wang YL; Lien PJ; Chao TC; Tseng LM
    Hum Pathol; 2017 Aug; 66():93-100. PubMed ID: 28603063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of mTOR Pathway Markers and Clinical Outcomes in Patients with Intermediate-/High-risk Prostate Cancer: Long-Term Analysis.
    Barata PC; Magi-Galluzzi C; Gupta R; Dreicer R; Klein EA; Garcia JA
    Clin Genitourin Cancer; 2019 Oct; 17(5):366-372. PubMed ID: 31262501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of Akt-1 in human prostate cancer: a computerized quantitative assessment with quantum dot technology.
    Li R; Dai H; Wheeler TM; Sayeeduddin M; Scardino PT; Frolov A; Ayala GE
    Clin Cancer Res; 2009 May; 15(10):3568-73. PubMed ID: 19417030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic non-coding RNA NEAT1 promotes the prostate cancer cell growth through the SRC3/IGF1R/AKT pathway.
    Xiong W; Huang C; Deng H; Jian C; Zen C; Ye K; Zhong Z; Zhao X; Zhu L
    Int J Biochem Cell Biol; 2018 Jan; 94():125-132. PubMed ID: 29225160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.